The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 990.00
Bid: 989.80
Ask: 990.40
Change: 2.60 (0.26%)
Spread: 0.60 (0.061%)
Open: 1,003.00
High: 1,008.00
Low: 985.40
Prev. Close: 987.40
PSON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

18 Dec 2019 07:00

RNS Number : 2420X
Pearson PLC
18 December 2019
 

Pearson agrees to sell remaining 25% stake in Penguin Random House to Bertelsmann, generating net proceeds of approximately $675m (£530m1), and announces a return of £350m to shareholders through a share buyback.

18th December 2019

 

Pearson, the world's learning company, today announces an agreement to sell its remaining 25% stake in Penguin Random House to partner Bertelsmann SE & Co KGaA ("Bertelsmann") for a consideration of approximately $675m / (£530m). The transaction is in line with Pearson's simplification strategy.

 

This transaction values the Penguin Random House venture at an enterprise value of $3.67bn, compared with the $3.55bn enterprise valuation in 2017 when Pearson sold a 22% stake in the joint venture.

 

The disposal is subject to regulatory consent and is expected to close in the first half of 2020 and therefore will have no impact on 2019 results. Pearson is committed to its disciplined approach to capital allocation and in early 2020 will commence a return of capital to shareholders through a £350m share buyback. Shares repurchased will be cancelled. The remainder of the proceeds will be used for general corporate purposes.

 

The formation of Penguin Random House in 2013 created the first truly global consumer book publishing company, with a significant market presence, generating synergies through the integration process and creating significant shareholder value. Our stake2 in Penguin Random House will have generated c.£1.9bn in net disposal proceeds and dividends.

 

Pearson owns 25% of the Penguin Random House venture which in 2018 reported revenue of $3,703m and EBIT of $467m as reported in € converted at a 2018 average €/$ exchange rate of 1.18, gross assets of $4,407m and net assets of $1,166m converted at a 2018 closing €/$ rate of 1.15. In 2018, Pearson's 25% associate share in the venture contributed £68m after tax to its adjusted operating profit.

 

John Fallon, Pearson's chief executive, said: "For almost 50 years, Pearson has been proud to play our part in the publishing and commercial success of first Penguin and then more recently Penguin Random House. With the sale of our remaining stake to our partners, Bertelsmann, we know the company is in good hands - and we wish our colleagues and authors every future success. This enables Pearson now to be completely focused on building the world's leading digital learning company, linking education to employability and skills, and reaching more learners around the world to support them through a lifetime of learning."

 

Notes:

1 Based on guidance $/£ exchange rates of 1.27.

2 47% stake held between 1st July 2013 and 5th October 2017, 25% stake held from 6th October 2017.

 

For more information

T + 44 (0)20 7010 2310

Investors: Jo Russell, Anjali Kotak

Press: Tom Steiner, Gemma Terry

 

This announcement contains inside information

 

Ends

 

Forward looking statements:

Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated cost savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future. There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, te risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (www.pearson.com/investors). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAEAPFFPNFEF
Date   Source Headline
19th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20234:50 pmRNSDirector/PDMR Shareholding
16th May 20234:16 pmRNSDirector/PDMR Shareholding
10th May 20234:30 pmRNSDirector/PDMR Shareholding
10th May 202310:49 amRNSDirectorate Change
9th May 20234:15 pmRNSHolding(s) in Company
9th May 20239:00 amRNSPearson: Generative AI Strategy Update
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
3rd May 20234:13 pmRNSHolding(s) in Company
2nd May 20233:57 pmRNSTotal Voting Rights
28th Apr 20231:11 pmRNSResult of AGM
28th Apr 20237:00 amRNSPearson 2023 Q1 Trading Update
20th Apr 20234:19 pmRNSHolding(s) in Company
11th Apr 20239:17 amRNSHolding(s) in Company
4th Apr 20234:30 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
31st Mar 20233:44 pmRNSForm 20-F for the year ended 31 December 2022
31st Mar 20232:29 pmRNSHolding(s) in Company
28th Mar 202311:17 amRNSDirector Declaration
27th Mar 20234:05 pmRNSHolding(s) in Company
24th Mar 202312:30 pmRNSNotice of AGM
23rd Mar 20237:00 amRNSPearson Completes Acquisition of PDRI
21st Mar 20237:00 amRNSPearson to sell POLS
16th Mar 20233:09 pmRNSAnnual Financial Report
16th Mar 202311:28 amRNSDirector Declaration
7th Mar 20234:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPearson 2022 Preliminary Results
2nd Mar 20233:37 pmRNSCommittee Change
1st Mar 202310:10 amRNSTotal Voting Rights
8th Feb 20232:37 pmRNSHolding(s) in Company
3rd Feb 20234:23 pmRNSDirector/PDMR Shareholding
1st Feb 202311:10 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSPearson 2022 Trading Update
4th Jan 20233:04 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSTotal Voting Rights
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
19th Dec 202212:00 pmRNSPearson to Acquire PDRI
16th Dec 20224:38 pmRNSCompletion of Redemption - Guaranteed Notes
14th Dec 20222:52 pmRNSSecond/Further Notice - Guaranteed Notes
7th Dec 20226:06 pmRNSTransaction in Own Shares
6th Dec 20226:02 pmRNSTransaction in Own Shares
5th Dec 20225:55 pmRNSTransaction in Own Shares
2nd Dec 20226:11 pmRNSTransaction in Own Shares
1st Dec 20225:44 pmRNSTransaction in Own Shares
1st Dec 20224:11 pmRNSBlock listing Interim Review
1st Dec 20224:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.